Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm
Conditions
Brief summary
This clinical trial studies how well a virtual community health educator (vCHE) works in increasing clinical trial referrals for patients with cancer and their caregivers. Low enrollment of underrepresented and underserved populations in cancer clinical trials has led to disparities in intervention development and implementation. One approach to recruiting diverse populations to cancer clinical trials is community health educators. However, community health educator interventions are costly and difficult to implement. vCHEs are photo-realistic virtual agents that provide personalized guidance and support to users. They are designed to mimic real-life community health workers, offering culturally and linguistically tailored information to users. They can communicate in English or Spanish and are available in diverse genders and racial/ethnic backgrounds. vCHEs may be able to increase the enrollment of diverse participants into cancer clinical trials.
Interventions
OTHERInternet-Based Intervention
Receive information via online text
OTHERQuestionnaire Administration
Ancillary studies
Receive information via ALEX Research Portal and vCHE
Sponsors
Mayo Clinic
National Cancer Institute (NCI)
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* Individuals Diagnosed with Cancer * 18 years or older * Must have received a cancer diagnosis at any point in your life * Able to understand English or Spanish * Care Partners * Must be a care partner (also known as caregiver, carer, supporter, helper, aide, assistant, companion, attendant, advocate, or family caregiver) of an adult who has received a cancer diagnosis * Must be actively involved in the decision-making process OR care of a person diagnosed with cancer * Must be 18 years or older
Exclusion criteria
* Self-reported: people who are currently or have been in a cancer clinical trial within the last 3 years
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Proportion of referrals to cancer clinical trials (CCTs) | Up to 3 months | Assessed by the number of referrals (patient self-referral or care partner referral) to an open cancer clinical trial (CCT). |
| Number of patient referrals sent by a healthcare provider by using the ALEX portal | Up to 3 months | Assessed by the number of referral sent by providers on a patient's behalf to a study coordinator for screening. |
Countries
United States
Contacts
CONTACTEnhancing Technology & Communication in Healthcare (ETCH) Lab
CONTACTClinical Trials Referral Office
PRINCIPAL_INVESTIGATORJanice L. Krieger, PhD
Mayo Clinic
Outcome results
None listed